# Jacques Genest

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jacques-genest/

## Facts

| Field | Value |
| --- | --- |
| Citations | 71,622 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 105 |
| i10-index | 545 |
| Last Known Institution | McGill University Health Centre |
| OpenAlex ID | https://openalex.org/A5022102417 |
| ORCID iD | https://orcid.org/0000-0003-2248-9663 |
| Works | 964 |

## Researcher papers

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [The Metabolic Syndrome and Cardiovascular Risk](https://scholariq.org/papers/the-metabolic-syndrome-and-cardiovascular-risk/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult](https://scholariq.org/papers/2016-canadian-cardiovascular-society-guidelines-for-the-management-of/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults](https://scholariq.org/papers/2021-canadian-cardiovascular-society-guidelines-for-the-management-of/)
- [Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel](https://scholariq.org/papers/defining-severe-familial-hypercholesterolaemia-and-the-implications-for-clinical/)
- [Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)](https://scholariq.org/papers/global-perspective-of-familial-hypercholesterolaemia-a-cross-sectional-study/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cholesterol and Lipid Metabolism](https://scholariq.org/topics/cholesterol-and-lipid-metabolism/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Researcher university

- [McGill University Health Centre](https://scholariq.org/institutions/mcgill-university-health-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.